VERACYTE, INC. AMENDED AND RESTATED CHANGE OF CONTROL AND SEVERANCE AGREEMENTChange of Control and Severance Agreement • July 30th, 2019 • Veracyte, Inc. • Services-medical laboratories • California
Contract Type FiledJuly 30th, 2019 Company Industry JurisdictionThis Amended and Restated Change of Control and Severance Agreement (the “Agreement”) is made and entered into by and between Keith Kennedy (“Executive”) and Veracyte, Inc., a Delaware corporation (the “Company”), effective as of July 1, 2019 (the “Effective Date”). This Agreement amends and restates the Change of Control and Severance Agreement by and between the Executive and the Company, effective as of October 23, 2018 (the “Prior Agreement”).
Services & Separation AgreementServices & Separation Agreement • July 30th, 2019 • Veracyte, Inc. • Services-medical laboratories • California
Contract Type FiledJuly 30th, 2019 Company Industry JurisdictionThis services and separation agreement (this “Agreement”) is between Christopher Hall (“you”) and Veracyte, Inc. (the “Company”) (collectively referred to as the “Parties” or individually referred to as a “Party”) concerning the terms of your continued services and separation from employment as provided herein. This Agreement is effective is as of the date it is signed by the Parties (the “Effective Date”).